Asensus Surgical
Logotype for Asensus Surgical Inc

Asensus Surgical (ASXC) investor relations material

Asensus Surgical has been acquired

Asensus Surgical M&A Announcement summary

Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.
Logotype for Asensus Surgical Inc
M&A Announcement summary21 Aug, 2024

Deal rationale and strategic fit

  • KARL STORZ acquires Asensus Surgical to create a surgical robotics hub and drive Performance-Guided Surgery, enhancing its position in the robotic and digital surgical market.

  • Asensus' expertise in robotic surgery and digital solutions complements KARL STORZ's endoscopy portfolio, supporting the development of the next-generation LUNA system.

  • The acquisition aligns with both companies' philosophies and visions, leveraging Asensus' talent and technology for global healthcare impact.

Financial terms and conditions

  • KARL STORZ acquired all outstanding shares of Asensus Surgical for $0.35 per share in cash.

  • Asensus Surgical has become a subsidiary of KARL STORZ, and its common stock has ceased trading on the NYSE American Exchange.

Synergies and expected cost savings

  • The combination is expected to accelerate the development and delivery of innovative robotic and digital surgical solutions, benefiting patients and surgeons worldwide.

  • Asensus' LUNA system, under development, is positioned to offer enhanced robotic precision and dexterity, complementing KARL STORZ's visualization capabilities.

Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
Research faster. Power your platform.
Asensus Surgical
Cover every name on your watchlist this earnings season.
Automations, AI chat, and live calls across 16,000+ companies.
Book demo

AI chat

Ask anything. Verify everything.

Ask across every event and document from public companies. Each answer links back to the exact line in the transcript, slide or filing it came from.Learn more

Find what matters

AI across all first-party IR material. Live calls, transcripts, slides, filings.
A cited source card from Adobe's CFO alongside a list of forward-looking statements

Trust every finding

50m+ first-party documents. Every output traceable to its source.

Automations

Zero in on what matters

Define the prompt once. It runs the moment a company publishes or on a schedule you set. Outputs map to the exact signals you choose.Learn more
An automation set to trigger on the first published earnings document for GE Aerospace

Event-triggered research

Runs when a company publishes new material. Trigger on the first published document for the earliest possible run, or wait for a specific one.
An automation scheduled to run weekly on Mondays at 09:00

Scheduled research

Runs on a recurring cadence you set. Daily, weekly, monthly, or quarterly, for aggregate reads across a period rather than a single event.

Live audio & transcripts

Be first

Join any earnings call live in one click, with no manual registration. Follow the transcript as it happens and jump straight to the moments that matter.Learn more
A live LVMH Q2 2026 earnings call playing in Quartr

Live earnings calls

Join any call in one click. The audio keeps playing while you work elsewhere in Quartr.
A live transcript excerpt from LVMH's Chairman and CEO Bernard Arnault

Live transcripts

Speaker-by-speaker, in real time. Searchable across every live and historical call.

Quartr MCP connects your AI environment to 17K+ public companies

Pull live transcripts, filings, and slides into Claude or Codex via MCP. Combine Quartr's global IR data with any other dataset. Run agentic research and monitoring.
Included with Quartr Pro at no extra cost.Learn more

Quartr's AI stands out because it only pulls clean, first-party data from public companies. In investing, that's everything.

Jamie Ross

Investment Manager, GAM Investments

GAM
GAM

Research that used to take hours now takes seconds with Quartr Pro. Tracking shifts in tone or extracting tables, it's as simple as typing a query.

Tom O'Hara

Investment Director

Ciena
Ciena

Before Quartr we spent hours manually compiling insights through the peer earnings cycle. Now, these tasks are done faster, with greater precision.

Gregg Lampf

VP of Investor Relations

Frequently asked questions

Asensus Surgical Inc. is a medical device company focused on developing and commercializing robotic-assisted surgical systems. Its flagship product, the Senhance Surgical System, uses augmented intelligence to enhance precision and control in minimally invasive surgeries. The company's technology is designed to improve surgeon performance, reduce variability in procedures, and enhance patient outcomes by integrating advanced robotics with digital capabilities. The company is headquartered in Durham, North Carolina, and its shares are listed on the NYSE.